Browse our anti-PKC alpha (PKCa) Antibodies

Xenopus laevis Protein Kinase C, alpha (PKCa) interaction partners

1. apically localized serine/threonine kinase aPKC directly phosphorylates an N-terminal site of the cell-cycle inhibitor p27Xic1 and reduces its ability to inhibit the cyclin-dependent kinase 2 (show CDK2 Antibodies), leading to shortening of G1 and S phases

2. Neural induction by Syn4 (show SNTG1 Antibodies) through the PKC (show PKC Antibodies) pathway requires inhibition of PKCdelta (show PKCd Antibodies) and activation of PKCalpha.

3. The depletion of membrane PIP(2) underlies receptor-mediated inhibition of IKs and that phosphorylation by PKC (show PKC Antibodies) of the KCNE1 (show KCNE1 Antibodies) subunit underlies the GqPCR-mediated channel activation.

4. Our data demonstrate isoform-specific regulation of closed-state inactivation by protein kinase C (show PKC Antibodies) in Kv4.3 (show KCND3 Antibodies)

Rhesus Monkey Protein Kinase C, alpha (PKCa) interaction partners

1. Data show that PKC (show PKC Antibodies) staining colocalizes with monkey retina expresses a retina-specific slice variant of PCP2 (show PCP2 Antibodies).

Human Protein Kinase C, alpha (PKCa) interaction partners

1. Regulation of vascular smooth muscle cell calcification by syndecan-4 (show SDC4 Antibodies)/FGF-2 (show FGF2 Antibodies)/PKCalpha signalling and cross-talk with TGF-beta1 (show TGFB1 Antibodies).

2. this study reveals a protective role for miR (show MLXIP Antibodies)-706 by blocking the oxidative stress-induced (show SQSTM1 Antibodies) activation of PKCalpha/TAOK1 (show TAOK1 Antibodies). Our results further identify a major implication for miR (show MLXIP Antibodies)-706 in preventing hepatic fibrogenesis and suggest that miR (show MLXIP Antibodies)-706 may be a suitable molecular target for anti-fibrosis therapy.

3. We also discuss the contribution of PKC (show PRRT2 Antibodies) enzymes to pancreatic diseases, including insulin (show INS Antibodies) resistance and diabetes mellitus, as well as pancreatitis and the development and progression of pancreatic cancer

4. data provided evidence that increased Rack1 (show GNB2L1 Antibodies)-mediated upregulation of PKC (show PRRT2 Antibodies) kinase activity may be responsible for the development of chemoresistance in T-ALL-derived cell line potentially by reducing FEM1b (show FEM1B Antibodies) and Apaf-1 (show APAF1 Antibodies) level.

5. Regulation of insulin exocytosis by calcium-dependent protein kinase C in beta cells has been summarized. (Review)

6. these data propose a mechanism where CD82 (show CD82 Antibodies) membrane organization regulates sustained PKCalpha signaling that results in an aggressive leukemia phenotype. These observations suggest that the CD82 (show CD82 Antibodies) scaffold may be a potential therapeutic target for attenuating aberrant signal transduction in acute myeloid leukemia (show BCL11A Antibodies) (AML (show RUNX1 Antibodies)).

7. MiR (show MLXIP Antibodies)-3148 may play an important role in the development of CTEPH. The key mechanisms for this miRNA may be hsa (show CD24 Antibodies)-miR (show MLXIP Antibodies)-3148-AR-pathways in cancer or hsa (show CD24 Antibodies)-miR (show MLXIP Antibodies)-3148-PRKCA-pathways in cancer/glioma/ErbB (show EGFR Antibodies) signaling pathway.

8. PRKCA is a recurrently mutated oncogene (show RAB1A Antibodies) in human chordoid glioma.

9. Our study showed that PKCalpha modulated cell resistance to apoptosis by stimulating NF-kappaB (show NFKB1 Antibodies) activation and thus promoted the tumorigenesis of bladder cancer.

10. PKCalpha translocation may occur as an early event in radiation-induced bystander responses.

Mouse (Murine) Protein Kinase C, alpha (PKCa) interaction partners

1. Results show that de novo polarisation of the embryo at the 8-cell stage is directed by phospholipase C (PLC (show PLC Antibodies)) and protein kinase C (PKC (show PKC Antibodies)).

2. LAV-BPIFB4 (show BPIFB4 Antibodies) isoform modulates eNOS (show NOS3 Antibodies) signalling through Ca2 (show CA2 Antibodies)+/PKC-alpha-dependent mechanism.

3. However, the mechanism that induces release of IL-6 (show IL6 Antibodies) from skeletal muscle cells remains unknown. Here we show that heat increases IL-6 (show IL6 Antibodies) in skeletal muscle cells through the transient receptor potential vannilloid 1, PKC (show PKC Antibodies), and cAMP response element-binding protein signal transduction pathway.

4. protein kinase (show CDK7 Antibodies) Calpha (show PRKACA Antibodies) (PKCalpha) gain of function mutations may promote synaptic defects in Alzheimer's disease

5. Erk5 (show MAPK7 Antibodies) MAP kinase (show MAPK1 Antibodies) is activated in response to PDGF (show PDGFA Antibodies)-BB in the smooth muscle cell line MOVAS in a manner dependent on Mekk2 (show MAP3K2 Antibodies), Mek1 (show MAP2K1 Antibodies)/2, Mek5 (show MAP2K5 Antibodies), PI3-kinase (show PIK3CA Antibodies) and protein kinase C (PKC (show PKC Antibodies)).

6. PKC-alpha plays a crucial role in the pathophysiology of peritoneal membrane dysfunction induced by peritoneal dialysis fluids, and its therapeutic inhibition might be a valuable treatment option for peritoneal dialysis patients.

7. these results identify PKCalpha and HMGB1 as important co-regulators involved in hydrogen peroxide-induced poly-ADP-ribose formation.

8. the present study demonstrates that nNOS-derived NO signaling modulated by spinal Sig-1R activation increases Nox2 activity and concomitant ROS production, which leads to a ROS-induced increase in PKC-dependent pGluN1 expression in the spinal cord dorsal horn and the development of pain hypersensitivity

9. We conclude that synaptotagmin-1 (show SYT1 Antibodies) phosphorylation is an essential step in PKC (show PKC Antibodies)-dependent potentiation of synaptic transmission, acting downstream of the two other essential DAG/PKC (show PKC Antibodies) substrates, Munc13-1 (show UNC13A Antibodies) and Munc18-1 (show STXBP1 Antibodies).

10. These data indicate that LPA (show LPA Antibodies) increases CCN2 (show CTGF Antibodies) expression through the activation of PKC (show PKC Antibodies) and PKA. Thus, the regulatory functions of the PKC (show PKC Antibodies) and PKA pathways are implicated in the LPA (show LPA Antibodies)-induced increase in CCN2 (show CTGF Antibodies) expression

Guinea Pig Protein Kinase C, alpha (PKCa) interaction partners

1. PKC (show PKC Antibodies) activation can enhance hippocampal neurotransmitter release, depending on changes specific to mGluR5 (show GRM5 Antibodies) and AMPA (show GRIA3 Antibodies)/kainate receptors.

2. Isoenzymes beta and delta of PKC have been found significantly phosphorylated, although their location was not changed as a consequence of Trichinella spiralis infection.

Cow (Bovine) Protein Kinase C, alpha (PKCa) interaction partners

1. AngII activates PKD via a mechanism involving Src family kinases and PKC, to underlie increased aldosterone production.

2. Significant changes in thin filament Ca2 (show CA2 Antibodies)+-sensitivity, structure and kinetics are brought about through PKC (show PKC Antibodies) phosphorylation of cardiac troponin T (show TNNT2 Antibodies).

3. Data indicate the involvement of PKC-alpha in proMMP-2 activation and inhibition of TIMP-2 (show TIMP2 Antibodies) expression by NF-kappaB (show NFKB1 Antibodies)-MT1-MMP (show MMP14 Antibodies)-dependent and -independent pathway.

4. calcium-dependent phosphorylation of argininosuccinate synthase (show ASS1 Antibodies) Ser (show SIGLEC1 Antibodies)-328 is mediated by PKCalpha

5. VDAC phosphorylation is an important determinant of its interaction with dimeric tubulin (show TUBB Antibodies).

6. Using yeast cells co-expressing the human wild-type p53 and a single mammalian PKCalpha, delta, epsilon or zeta, results showed a differential regulation of p53-mediated apoptosis by these PKC isoforms.

7. degradation of protein kinase C(alpha)in sperm capacitation is mediated by PRKA (show Akap6 Antibodies)

8. Data suggest that ceramide interacts with the calcium-dependent lipid binding C2 domain of protein kinase C alpha and thereby induces translocation of the enzyme to the Golgi compartment.

9. analysis of amino acid critical for the catalytic competence and function of protein kinase (show CDK7 Antibodies) Calpha (show PRKACA Antibodies)

10. By regulating VEGFR2 (show KDR Antibodies) expression and activation, PKC-epsilon (show PRKCE Antibodies) expression is critical for activation of Akt (show AKT1 Antibodies) and eNOS (show NOS3 Antibodies) by VEGF (show VEGFA Antibodies) and contributes to VEGF (show VEGFA Antibodies)-stimulated Erk (show MAPK1 Antibodies) activation, whereas PKC-alpha has opposite effects.

Rabbit Protein Kinase C, alpha (PKCa) interaction partners

1. High PKC alpha expression is associated with retinal neovascularization.

2. We conclude that ouabain, even at low concentrations (0.5-8.0 mum), can increase INaL and reverse INCX , and these effects may contribute to the effect of the glycoside to increase Ca(2 (show CA2 Antibodies)+) transients and contractility.

3. These results suggest a complex antagonistic interplay between G(q)-activated PKC and Gbetagamma in regulation of L-VDCC, in which multiple cytosolic segments of alpha(1C) are involved.

4. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.

Pig (Porcine) Protein Kinase C, alpha (PKCa) interaction partners

1. This study examined the protein expression and spatial-temporal distribution of PKCalpha and CPI-17 (show PPP1R14A Antibodies) in intact smooth muscle tissues.

2. Results suggest that the action of genistein on protein kinase A is mediated via adenylate cyclase, but does not appear to involve Gs protein or ICI 182780-sensitive estrogen receptor (show ESR1 Antibodies).

3. The PKCalpha, PKCbeta1, and PKCbeta2 mRNA levels tended to be lower in ischemia-reperfused than in sham-operated eyes in both the retinal arteries and the neuroretina.

4. protein level of retinal PKC-alpha is increased with maturation